Vaccination with SesC Decreases Staphylococcus epidermidis biofilm formation

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3660-3668

  Shahrooei, Mohammad ^a   Hira, Vishal ^b   Khodaparast, Laleh ^a   Khodaparast, Ladan ^a   Stijlemans, Benoit ^c   Kucharíková, Soňa ^d   Burghout, Peter ^e   Hermans, Peter W M ^e   Van Eldere, Johan ^a  

^a REGA INSTITUTE   (Belgium)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; RECOMBINANT PROTEIN; RECOMBINANT SESC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BIOFILM; COMPUTER MODEL; CONTROLLED STUDY; DRUG INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STAPHYLOCOCCUS EPIDERMIDIS; VACCINATION;

ADAPTATION, BIOLOGICAL; AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BIOFILMS; CATHETERS; CLONING, MOLECULAR; COMPUTER SIMULATION; FOREIGN BODIES; GENE EXPRESSION REGULATION, BACTERIAL; IMMUNOGLOBULIN G; MICE; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; RABBITS; RATS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VACCINATION;

EID: 84867616248     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00104-12     Document Type: Article

References (42)

1. Allgaier H, Jung G, Werner RG, Schneider U, Zahner H. 1985. Elucidation of the structure of epidermin, a ribosomally synthesized, tetracyclic heterodetic polypeptide antibiotic. Angew. Chem. Int. Ed. 24:1051-1053.
2. Arrecubieta C, Lee MH, Macey A, Foster TJ, Lowy FD. 2007. SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J. Biol. Chem. 282:18767-18776.
3. Bogaert D, et al. 2005. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media. Vaccine 23:2607-2613.
4. Bowden MG, et al. 2005. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 151:1453-1464.
5. Cerca N, Jefferson MK, Oliveira R, Pier GB, Azeredo J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect. Immun. 74:4849-4855.
6. Christensen GD, et al. 1985. Adherence of coagulase-negative staphylococci to plastic tissue-culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006.
7. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
8. Cucarella C, et al. 2001. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J. Bacteriol. 183:2888-2896.
9. Danese PN. 2002. Antibiofilm approaches: prevention of catheter colonization. Chem. Biol. 9:873-880.
10. Davis SL, Gurusiddappa S, Mccrea KW, Perkins S, Hook M. 2001. SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognizing adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the B beta chain. J. Biol. Chem. 276:27799-27805.
11. Desvaux M, Dumas E, Chafsey I, Hebraud M. 2006. Protein cell surface display in Gram-positive bacteria: from single protein to macromolecular protein structure. FEMS Microbiol. Lett. 256:1-15.
12. Gill SR, et al. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
13. Gotz F. 2004. Staphylococci in colonization and disease: prospective targets for drugs and vaccines. Curr. Opin. Microbiol. 7:477-487.
14. Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. 1997. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect. Immun. 65: 519-524.
15. Illingworth B, Bianco RW, Weisberg S. 2000. In vivo efficacy of silvercoated fabric against Staphylococcus epidermidis. J. Heart Valve Dis. 9:135-141.
16. Kockro RA, et al. 2000. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J. Med. Microbiol. 49:441-450.
17. Lazzell AL, et al. 2009. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J. Antimicrob. Chemother. 64:567-570.
18. Mack D, Siemssen N, Laufs R. 1992. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect. Immun. 60:2048-2057.
19. Maira-Litran T, Kropec A, Goldmann D, Pier GB. 2004. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine 22:872-879.
20. Mccann MT, Gilmore BF, Gorman SP. 2008. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J. Pharm. Pharmacol. 60:1551-1571.
21. Oosterlinck W, Vanderper A, Flameng W, Herijgers P. 2011. Glucose tolerance and left ventricular pressure-volume relationships in frequently used mouse strains. J. Biomed. Biotechnol. 2011:281312. doi:10.1155/2011/281312.
22. Otto M. 2009. Staphylococcus epidermidis: the "accidental" pathogen. Nat. Rev. Microbiol. 7:555-567.23.
23. Pei L, Flock JI. 2001. Functional study of antibodies against a fibrogeninbinding protein in Staphylococcus epidermidis adherence to polyethylene catheters. J. Infect. Dis. 184:52-55.
24. Pintens V, et al. 2008. The role of sigma(B) in persistence of Staphylococcus epidermidis foreign body infection. Microbiology 154:2827-2836.
25. Raad I, Alrahwan A, Rolston K. 1998. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin. Infect. Dis. 26:1182-1187.
26. Scott JR, Barnett TC. 2006. Surface proteins of Gram-positive bacteria and how they get there. Annu. Rev. Microbiol. 60:397-423.
27. Sellman BR, Howell AP, Kelly-Boyd C, Baker SM. 2005. Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect. Immun. 73:6591-6600.
28. Shahrooei M, et al. 2009. Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect. Immun. 77:3670-3678.
29. Smith EJ, Visai L, Kerrigan SW, Speziale P, Foster TJ. 2011. The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect. Immun. 79:3801-3809.
30. Soderquist B. 2007. Surgical site infections in cardiac surgery: microbiology. APMIS 115:1008-1011.
31. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
32. Sun DQ, Accavitti MA, Bryers JD. 2005. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin. Diagn. Lab. Immunol. 12:93-100.
33. Sutcliffe IC, Harrington DJ. 2002. Pattern searches for the identification of putative lipoprotein genes in Gram-positive bacterial genomes. Microbiology 148:2065-2077.
34. Sutcliffe IC, Harrington DJ. 2004. Putative lipoproteins of Streptococcus agalactiae identified by bioinformatic genome analysis. Antonie Van Leeuwenhoek Int. J. Gen. Mol. Microbiol. 85:305-315.
35. Vandecasteele SJ, Peetermans WE, Merckx R, Van Eldere J. 2001. Quantification of expression of Staphylococcus epidermidis housekeeping genes with TaqMan quantitative PCR during in vitro growth and under different conditions. J. Bacteriol. 183:7094-7101.
36. van der Borden AJ, van der Werf H, van der Mei HC, Busscher HJ. 2004. Electric current-induced detachment of Staphylococcus epidermidis biofilms from surgical stainless steel. Appl. Environ. Microbiol. 70:6871-6874.
37. Van Mellaert L, Shahrooei M, Hofmans D, Van Eldere J. 2012. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Expert Rev. Vaccines 11:319-334.
38. Van Wijngaerden E, et al. 1999. Foreign body infection: a new rat model for prophylaxis and treatment. J. Antimicrob. Chemother. 44:669-674.
39. Wegmann U, et al. 2007. Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp cremoris MG1363. J. Bacteriol. 189:3256-3270.
40. Yu B, Davis EM, Hodges RS, Irvin RT, Li DY. 2008. Surface nanocrystallization of stainless steel for reduced biofilm adherence. Nanotechnology 19(33):335101. doi:10.1088/0957-4484/19/33/335101.
41. Yu B, Lesiuk A, Davis E, Irvin RT, Li DY. 2010. Surface nanocrystallization for bacterial control. Langmuir 26:10930-10934.
42. Zhang YQ, et al. 2003. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol. Microbiol. 49:1577-1593. Shahrooei et al. 3668